about
Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis.Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes.Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer.EMT and Treatment Resistance in Pancreatic Cancer.Role of surgery in pancreatic cancerPhase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma.Stereotactic body radiotherapy for locally-advanced unresectable pancreatic cancer-patterns of care and overall survival.Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors.Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer.Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma.Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.
P2860
Q37716482-B855F212-87AA-4D07-80D5-0DF45BBE85F8Q39359422-B3D00AE1-68D4-4EA5-A34E-046ED5717F0FQ41463557-EB12AF6A-B023-4032-8DCE-98621D77724CQ41670877-F9444B1B-EC9B-4924-9B69-7E64964FA69BQ42339996-F0C20321-C847-4AC1-A9EF-92875D3AB185Q45072406-F3F92CBB-D4F7-4845-A855-FD79049030C8Q47146583-7F702975-86B5-4AD0-8323-08E828100389Q47712161-41191FA1-BBA9-4127-AEDB-D651D4EAA3BEQ50930412-BFB86D8C-9762-4EFF-9890-4F0166940E3CQ51733921-79940266-AC2F-44FE-B6EA-86D14EFD25A1Q54980764-2DBDAFEE-CB30-41A7-A992-6D9DF01206BF
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Immune checkpoint therapy for pancreatic cancer
@ast
Immune checkpoint therapy for pancreatic cancer
@en
Immune checkpoint therapy for pancreatic cancer
@nl
type
label
Immune checkpoint therapy for pancreatic cancer
@ast
Immune checkpoint therapy for pancreatic cancer
@en
Immune checkpoint therapy for pancreatic cancer
@nl
prefLabel
Immune checkpoint therapy for pancreatic cancer
@ast
Immune checkpoint therapy for pancreatic cancer
@en
Immune checkpoint therapy for pancreatic cancer
@nl
P2093
P2860
P921
P356
P1476
Immune checkpoint therapy for pancreatic cancer
@en
P2093
Daniel Ansari
Henrik Johansson
Monika Bauden
Roland Andersson
Sarah Hammes
Stefan Holdenrieder
P2860
P304
P356
10.3748/WJG.V22.I43.9457
P407
P5008
P577
2016-11-21T00:00:00Z